carbachol has been researched along with mitomycin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| de las Alas, MM; Doria, M; Gaginella, TS; Kachur, JF; Keshavarzian, A; Sundaresan, R; Walsh, R | 1 |
| Gordon, TP; Haberberger, RV; Jackson, MW; Park, K | 1 |
3 other study(ies) available for carbachol and mitomycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Colitis reduces short-circuit current response to inflammatory mediators in rat colonic mucosa.
Topics: Alprostadil; Animals; Anions; Bradykinin; Carbachol; Colitis; Intestinal Mucosa; Male; Mitomycin; Neutrophils; Patch-Clamp Techniques; Peroxidase; Rats; Rats, Sprague-Dawley; Second Messenger Systems; Secretory Rate; Serotonin; Substance P; Theophylline; Time Factors | 1995 |
Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome.
Topics: Acetylcholine; Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Carbachol; Cholinergic Agonists; Cisplatin; Gastrointestinal Motility; Humans; Ifosfamide; Male; Mice; Mice, Knockout; Mitomycin; Muscle Contraction; Muscle, Smooth; Receptor, Muscarinic M3; Sjogren's Syndrome; Synaptic Transmission | 2011 |